BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 492553)

  • 1. [Incidence of cryoglobulinemia in a series of cases of chronic liver diseases].
    Ruggiero G; Spadacenta F; Gargiulo M; Miraglia E; Gianturco G
    Minerva Med; 1979 Sep; 70(42):2863-7. PubMed ID: 492553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
    Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
    Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryoglobulinemia in chronic liver diseases.
    Shoenfeld Y; Berliner S; Neeman A; Kadish U; Pinkhas J
    Am J Gastroenterol; 1980 Nov; 74(5):439-40. PubMed ID: 7234822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and natural history of chronic persistent hepatitis. A multicentre retrospective study on 1197 cases.
    Giusti G; Galanti B; Gaeta GB; Sagnelli E; Piccinino F; Ruggiero G
    Ital J Gastroenterol; 1991; 23(3):111-8. PubMed ID: 1742503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of detailed hepatitis B virus serology in chronic liver diseases.
    Horváth G; Tolvaj G; Stotz G; Dávid K
    Acta Med Hung; 1992-1993; 49(1-2):119-28. PubMed ID: 1296181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryoglobulins in patients with acute hepatitis and inflammatory bowel disease.
    Levo Y
    Hepatogastroenterology; 1982 Dec; 29(6):246-8. PubMed ID: 7152458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic HB virus hepatitis in children. A study of 29 cases].
    Maggiore G; Marzani D; De Giacomo C; Sessa F; Civardi G; Scotta MS
    Sem Hop; 1984 May; 60(19):1349-52. PubMed ID: 6326326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of HB virus infection in an area of Japan with high incidence of liver cirrhosis and hepatocellular carcinoma: an analysis of consecutive studies among inhabitants of Tomié-Town, Goto Islands.
    Munehisa T; Nakata K; Fukahori A; Muro T; Kono K; Furukawa R; Kusumoto Y; Iwanaga A; Ishii N; Koji T
    Am J Gastroenterol; 1984 Aug; 79(8):633-6. PubMed ID: 6087656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood amino acids in chronic HBsAg positive liver disease].
    De Marco F; Palmieri G; Capuano G; Gentile R; Nardone G; Parrilli G; Prantera T; Budillon G
    Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1576-81. PubMed ID: 6661322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Essential mixed cryoglobulinaemia and hepatitis B virus (author's transl)].
    Garcia-Bragado F; Vilardell M; Fonollosa V; Ruibal A; Gallart T; Cuxart A
    Nouv Presse Med; 1981 Oct; 10(36):2955-7. PubMed ID: 7290950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
    Stránský J; Zichová M; Vodák M
    Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of detailed Hepatitis B virus marker studies in chronic liver diseases].
    Horváth G; Tolvaj G; Dávid K
    Orv Hetil; 1992 Jul; 133 Suppl 1():9-13. PubMed ID: 1630808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic histology in chronic liver disease in hepatitis B surface antigen positive cases.
    Ghosh AK; Dasgupta A; Raha K; Jana A; Majumdar DN
    J Indian Med Assoc; 1994 Oct; 92(10):333-5. PubMed ID: 7822848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic reactivity of the skin in chronic hepatitis].
    Fuchs H
    Ann Acad Med Stetin; 1990; 36():61-75. PubMed ID: 2099109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and outcomes of HBV and anti-HCV seropositive patients with chronic liver disease and hepatocellular carcinoma.
    Pramoolsinsap C; Sumalnop K; Busagorn N; Kurathong S
    Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):6-11. PubMed ID: 1326124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H; Fay O; Roldán L; Vorovioff J
    Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
    Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
    Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum cholinesterase activity (CHE) in different classes of chronic liver diseases (author's transl)].
    Galanti B; Russo M; Nardiello S; Guarino F
    Quad Sclavo Diagn; 1978 Mar; 14(1):95-102. PubMed ID: 746115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
    Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
    Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum HBV-DNA (hepatitis B virus DNA) in acute and chronic hepatitis B infection.
    Feinman SV; Berris B; Fay O; Sooknanan R; Tanno HE; Tung WW; Lieberman HM
    Clin Invest Med; 1988 Aug; 11(4):286-91. PubMed ID: 3168350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.